CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Ablynx N.V. Company Snapshot
Ablynx N.V. operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ablynx N.V. with three other miscellaneous service companies in Europe: Karo Pharma AB of Sweden (2017 sales of 657.61 million Swedish Kronor [US$75.67 million] ), Ergomed PLC of the United Kingdom (£47.62 million [US$64.01 million] of which 54% was Clinical Research Service), and Circassia Pharmaceuticals PLC which is also based in the United Kingdom (£46.30 million [US$62.23 million] of which 59% was operating-NIOX).

Sales Analysis. During the year ended December of 2017, sales at Ablynx N.V. were 55.53 million Euro (US$65.41 million). This is a sharp decrease of 34.8% versus 2016, when the company's sales were 85.19 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Ablynx N.V.
  Stock Performance Chart for Ablynx N.V.
 
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 44.96
(Figures in Euro)
1 Week 0.3%   13 Weeks 0.6%  
4 Weeks 2.6%   52 Weeks 308.4%  
 
Ablynx N.V. Key Data:
  Ticker: ABLX Country: Belgium
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 55,531,000
(Year Ending Jan 2018).
Employees: 438
  Currency: Euro Market Cap: 3,359,440,154
  Fiscal Yr Ends: December Shares Outstanding: 74,720,644
  Share Type: ACTIONS ORDINAIRES Closely Held Shares: 2,756,641
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.